Methamphetamine

Methamphetamine is a powerful stimulant that can cause significant health issues and is often used recreationally despite its dangers. Studies have linked methamphetamine use to cardiovascular disease, including an increased risk of heart attacks and strokes. It has also been associated with pulmonary arterial hypertension, a condition where high blood pressure affects the arteries in the lungs. Additionally, methamphetamine can lead to neurological conditions such as catatonia and may increase the risk of early-onset stroke and Parkinson's disease. Methamphetamine use is on the rise, and deaths related to it are increasing, highlighting the need for better diagnostic tools and treatment options.

Methamphetamine's impact extends beyond individual health; it affects communities by contributing to higher healthcare costs and social issues. The drug's association with severe cardiovascular and neurological conditions underscores its potential for long-term harm. However, more research is needed to fully understand the mechanisms behind these effects and to develop effective interventions.

The evidence base for some of these findings is limited, particularly in terms of long-term outcomes and specific subpopulations.

Sources

• Methamphetamine Use and Cardiovascular Disease. (PMID:31433698)
• Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. (PMID:25176528)
• Methamphetamine-associated pulmonary arterial hypertension. (PMID:35838374)
• Methamphetamine deaths: Changing trends and diagnostic issues. (PMID:33423599)
• Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020. (PMID:37459499)
• Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review. (PMID:34166684)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._